The Therapeutic Goods Administration (TGA), a regulatory authority that’s part of the Australian Government Department of Health, is responsible for regulating the sale, supply, manufacture, and distribution of therapeutic goods in Australia, including different types of medicine and medical devices. Manufacturers and suppliers of medical devices must comply with obligations set out by the TGA before their products can be sold in Australia. Every company needs to be knowledgeable about them because they first need to obtain TGA approval for medical devices to stay compliant.
The journey to achieving compliance can be complex, often fraught with nuances in interpretation and documentation that only specialists with deep experience in the TGA framework fully understand. This complexity makes expert guidance not just helpful, but critical for minimizing delays and maximizing efficiency.
If you manufacture and supply therapeutic goods, such as medicines and medical devices, and are looking to place your products on the Australian market, this post is for you. Get to know the regulatory processes surrounding the approval of medical device supplies in the Australian market, and discover how a medical device sponsor can assist you.
Regulatory Guidelines on Medical Devices Distributed in the Australian Market
Intending to improve the health and well-being of all Australians, the TGA ensures that medical devices available in Australia are safe and suitable for their intended purpose. Medical devices must be assessed and included in the Australian Register of Therapeutic Goods (ARTG) database before they can be legally supplied or exported from Australia.
The Australian Regulatory Guidelines for Medical Devices (ARGMD) provides details about the classes of medical devices, safety, risks, performance, and the clinical evidence necessary to support the registration of the inclusion of a medical device product on the ARTG. These guidelines ensure that medical device manufacturers comply with the safety, performance, and quality requirements of the products they’re planning to place on the market.
Navigating the ARGMD requires more than simply reading the documents; it demands practical, working knowledge of how the TGA applies these rules during assessment. A failure to correctly interpret and execute the ARGMD’s requirements is a primary cause of rejection or extensive information requests.
Ultimately, you are required to comply with the guidelines outlined in the ARGMD if you intend to:
- Supply medical devices in the Australian market
- Export manufactured medical devices to overseas markets
- Manufacture and import medical devices into the Australian market
Where to Get Updates on TGA Requirements
The TGA continuously updates the guidelines of the ARGMD and will add information and links to further guidance when available. Here are other ways you can obtain information about changes to the TGA medical device regulations in the Australian market:
- Subscribing to the fortnightly TGA UPDATE email
- Keeping up with the Consultations and reviews page
- Keeping up to date with the progress of the Medical Devices Reforms page
- Hiring a medical device regulatory consultant
How Do Medical Devices Get Approved?
Every ARTG application must come from an Australian-based device sponsor. If you aim to sell or distribute a therapeutic good, you must that ensure that your application has been approved and that the TGA has included your device on the Australian Register of Therapeutic Goods (ARTG) and issued you with an ARTG Certificate.
The TGA uses a risk-based approach in evaluating the products. This means that higher-risk therapeutic goods undergo a more extensive assessment than lower-risk goods. Once the TGA approves a medical device, it will be listed in the ARTG.
Understanding and classifying your device’s risk correctly is the critical foundation of the entire ARTG inclusion process. An incorrect initial classification will invalidate the subsequent regulatory pathway and lead to significant delays, re-work, and wasted resources. This step alone justifies seeking advice from those who have direct experience seeking TGA approval for medical devices and reviewing such classifications within the TGA.
The TGA will also continuously monitor the therapeutic goods’ risks and benefits and take necessary action if the benefits are not realised, or additional risks become evident. These regulatory actions may vary, from continuous monitoring to withdrawing a product from the market.
What Is a Conformity Assessment?
To meet the legal and regulatory standards for TGA approval in Australia, manufacturers must undergo a conformity assessment before their devices can be included in the ARTG.
This assessment ensures the device meets the TGA’s essential principles for safety, performance, and quality. For high-risk products like implantables or life-supporting devices, the TGA may carry out the assessment itself or review certification from recognised international regulators. However, local evidence still needs to meet TGA formatting and procedural expectations.
Completing the conformity assessment correctly on the first attempt helps avoid information requests and unnecessary approval delays, particularly for new entries in the process for medical devices TGA approval in Australia.
Submitting a conformity assessment is a high-stakes moment. Any weakness in the documented evidence, particularly regarding manufacturing quality systems or clinical support, will be flagged immediately. An expert review before submission is the best defense against assessment setbacks, ensuring your documentation anticipates and satisfies the TGA’s detailed scrutiny.
TGA Medical Device Approval Timeline
Aside from the medical device classification, the medical device assessment timeframe will vary based on a few circumstances, including:
- If the application lodged is complete, including all the necessary information
- How quickly a sponsor responds to requests for additional information
- If the clinical information aligns with the requirements
For example, in the year 2018-19 (for 90% of applications), the average processing times for the ARTG inclusion was 42 days for Class 1 Sterile medical devices, 97 days for Class I (measuring) medical devices, and 188 days for Class IIa.
What Is Risk-Based Classification?
Understanding the TGA’s risk-based classification system is fundamental for medical device sponsors and manufacturers. Each device is categorised based on its level of risk to the patient or user, taking into account factors such as how long it remains in the body, whether it has a measuring function, and whether it delivers medication or energy.
Sponsors and manufacturers must ensure that the classification aligns with the latest TGA guidelines before initiating the application process. When preparing for medical devices TGA approval in Australia, verifying the correct classification early can help ensure a smoother path through the regulatory process.
The Role of a Medical Device Sponsor for Medical Device Approval
With the complexity of obtaining TGA approval for medical device supply and distribution in Australia, it’s natural to seek the right help to ensure you’re taking steps in the right direction. As outlined above, you need a TGA sponsor to ensure that your medical device supply complies with regulatory requirements.
Sponsors should know the requirements for each type of medical device application and prepare the documentation necessary upon application submission. Your sponsor will help speed up the assessment process by reducing the TGA’s need to request further information. Sponsors should also be prepared to respond to any requests for additional information.
They can also import, export, and manufacture therapeutic goods. Sponsors must be residents of Australia or at least conduct business in Australia.
The key to selecting the right sponsor is experience. A seasoned sponsor, particularly one with internal TGA knowledge, offers invaluable strategic advice that goes beyond mere administration. They can proactively structure your submission to meet unspoken expectations and efficiently handle technical enquiries, dramatically cutting down the total time to market.
The Importance of Clinical Evaluation for TGA Approval
A complete and well-structured clinical evaluation is another essential part of obtaining TGA approval in Australia. For moderate- and high-risk devices, the TGA requires clinical evidence based on published literature, clinical trials, or comparative market data. If your device is new or lacks prior use in comparable international markets, additional clinical investigations may be required.
Submitting a weak or inconsistent clinical evaluation report is a common reason for assessment delays or post-market scrutiny.
Medical Device Sponsor in Australia
Are you a medical device manufacturer or supplier planning to penetrate the Australian market? As outlined above, obtaining TGA approval for medical devices can be lengthy and distressing. Maybe you’re like most businesses, unsure of what’s required to get your therapeutic goods approved and ready for sale in the Australian healthcare industry. Fortunately, Vicki Partridge is here.
Vicki is a medical device regulatory consultant who will ensure that your medical devices are put through the necessary processes to be included in the ARTG before legally supplying them to the market. She can handle all the paperwork for you, taking away the hassles and letting you focus on your business while keeping you abreast of each step she takes.
If you are looking for a reliable and highly experienced medical device sponsor in Australia, entrust the complexities of medical device assessments to Vicki Partridge. Backed by her years of work experience in the TGA and her familiarity with the regulatory framework, she can guarantee that every medical device request for approval and inclusion will be successful.
Get in touch with Vicki’s office by calling +61 7 55295508.